DOX vs CNXC

For growth investors, Concentrix Corporation (CNXC) is the stronger pick with 2.

2% revenue growth year-over-year, versus -9. 4% for Amdocs Limited (DOX). Amdocs Limited (DOX) offers the better valuation at 12. 7x trailing P/E (8. 6x forward), making it the more compelling value choice. Analysts rate Amdocs Limited (DOX) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Concentrix Corporation is actually cheaper at 2.

0x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Amdocs Limited (DOX) delivered a total return of -5.

2%, compared to -81. 0% for Concentrix Corporation (CNXC). Over 10 years, the gap is even starker: DOX returned +36. 3% versus CNXC's -63. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Amdocs Limited (DOX) is the lower-risk stock at 0.

58β versus Concentrix Corporation's 1. 38β — meaning CNXC is approximately 140% more volatile than DOX relative to the S&P 500. On balance sheet safety, Amdocs Limited (DOX) carries a lower debt/equity ratio of 24% versus 169% for Concentrix Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Concentrix Corporation (CNXC) is pulling ahead at 2.

2% versus -9. 4% for Amdocs Limited (DOX). On earnings-per-share growth, the picture is similar: Amdocs Limited grew EPS 18. 8% year-over-year, compared to -648. 8% for Concentrix Corporation. Over a 3-year CAGR, CNXC leads at 15. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Amdocs Limited (DOX) is the more profitable company, earning 12.

5% net margin versus -13. 0% for Concentrix Corporation — meaning it keeps 12. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DOX leads at 18. 2% versus 6. 2% for CNXC. At the gross margin level — before operating expenses — DOX leads at 36. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Concentrix Corporation (CNXC) trades at 2.

0x forward P/E versus 8. 6x for Amdocs Limited — 6. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CNXC: 119. 2% to $52. 00.

All stocks in this comparison pay dividends.

Concentrix Corporation (CNXC) offers the highest yield at 6. 0%, versus 3. 1% for Amdocs Limited (DOX).

For long-horizon retirement investors, Amdocs Limited (DOX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

58), 3. 1% yield). Both have compounded well over 10 years (DOX: +36. 3%, CNXC: -63. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: DOX is a small-cap deep-value stock; CNXC is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.